Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-23

Clinical Trial Update: Anrikefon vs Nalfurafine for Sleep Quality in Hemodialysis Patients With CKD-aP [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Anrikefon versus Nalfurafine for sleep quality in patients with chronic kidney disease-associated pruritus; the study status is not yet …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Anrikefon
  • Nalfurafine (nalfurafine)

Snippet

Sponsor: Zhujiang Hospital | Conditions: Pruritus Chronic, Kidney Diseases, Chronic | Phase 4 | Status: NOT_YET_RECRUITING